Movement Alert|FuelCell Rises 8.43% in Regular Trading, Multiple Investment Banks Initiate Coverage Amid Data Center Order Momentum

Market Focus
Sep 29

On September 29, FuelCell rose 8.43% in regular trading, trading at $17.5 per share, with turnover of approximately $22.6 million. The rally was primarily driven by a wave of investment bank coverage initiations and growing optimism around data center power supply opportunities.

On the news front, Barclays recently initiated coverage on FuelCell with an Equalweight rating and a $20 price target, while Citigroup initiated at Neutral with a $19 target. Earlier, UBS upgraded the stock to Buy from Neutral, raising its price target to $27 from $22, citing meaningful sales upside from the Fit Energy USA agreement and a Siemens collaboration on distributed fuel cell power generation. The current analyst consensus rating stands at Overweight, with a mean target price of $20.78, implying roughly 19% upside from current levels.

Despite a Q3 fiscal earnings miss — with adjusted EPS of -$0.64 versus the -$0.41 estimate and revenue of $33.0 million versus the $38.8 million estimate — the company has secured its first data center power supply contract and accumulated a $1.3 billion order backlog, signaling a strategic pivot toward capacity expansion and positioning in the medium-scale distributed energy market.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10